NOV 25, 2019 10:01 AM PST

Darobactin: Promising New Drug to Combat Antibiotic Resistance

WRITTEN BY: Annie Lennon

Every year, around 700,000 people are estimated to die from drug-resistant infections thanks to our overuse of antibiotics both in agriculture and medicine. With this figure estimated to grow into the millions within the coming decades, researchers are scrambling to find new ways to treat infections. Now, researchers from Justus Liebig University Giessen have discovered a new peptide from the gut of a parasitic worm that may be able to help. 

Known as Darobactin, the peptide works against gram negative bacteria which, due to their highly restrictive cell walls, are immune to most antibiotics. Gram negative bacteria are common; examples including Escherichia coli (E. Coli) and Klebsiella pneumoniae (pneumonia) which have become immune to most treatment due to this cellular feature, thus prompting heavy research into tackling gram negative bacteria. 

The epitome of two years of research, Darobactin emerged as a possible antibiotic from analyzing the Photorhabdus bacteria, found in the gut of a small parasitic worm known as a nematode. The worm first caught researchers attention due to its ability to feed on insects, targeting their larvae and releasing bacteria that combat pathogens similar to those present in the human gut. Isolating the worm’s gut bacteria, the researchers were then able to find Darobactin which, after screening, was then experimented with to treat bacterial infections common in humans. 

So far, usage of the peptide has been successful. In experiments with mice, it has successfully managed to eradicate several bacterial strains including previously antibiotic-resistant strains of E Coli and pneumonia. From examining it in the lab, researchers saw that it works by binding to the BamA protein, found on the external membrane of gram negative bacteria. This then leads the bacteria to malfunction, and eventually die off. 

According to Professor Till Schaeberie from the Institute of Insect Biotechnology, “"It is particularly interesting to note that this previously unknown weak point is located on the outside of the bacteria where substances can easily reach it." 

Although Darobactin shows a lot of promise as an upcoming antibiotic, as human trials have yet to be conducted, it will take some time for the peptide to be able to treat human infections. Despite this however, the researchers remain optimistic that their experiments with Darobactin demonstrate a clear potential for its development as a therapeutic


Sources: Science Alert, Science Daily and Nature

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 09, 2020
Drug Discovery & Development
Psychedelic DMT Improves Wellbeing in 89% of People
JUN 09, 2020
Psychedelic DMT Improves Wellbeing in 89% of People
DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and dei ...
JUN 16, 2020
Microbiology
Dexamethasone Hailed as Effective COVID-19 Treatment
JUN 16, 2020
Dexamethasone Hailed as Effective COVID-19 Treatment
The pandemic virus SARS-CoV-2, which causes COVID-19, has killed more than 438,000 people worldwide since it emerged lat ...
JUL 19, 2020
Drug Discovery & Development
Nanodrug for Treating Invasive Breast Cancer
JUL 19, 2020
Nanodrug for Treating Invasive Breast Cancer
Scientists at the University of Arkansas created a nano-drug that may eradicate triple-negative breast cancer cells. Fin ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
JUL 21, 2020
Drug Discovery & Development
New Drug Discoveries are Due To Good Labs
JUL 21, 2020
New Drug Discoveries are Due To Good Labs
A study suggests that the quality of lab procedures performed heavily influences the rate of drug discoveries. These fin ...
AUG 06, 2020
Immunology
Resetting the Body's Danger Sensor
AUG 06, 2020
Resetting the Body's Danger Sensor
The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. T ...
Loading Comments...